Toledo Blade
... up from $349 million a year before, but sharply below the $529 million expected by analysts. That resulted in its stock dropping in after-hours trading.
Welcome to my new trading blog based of after hours stocks. Please subscribe for updates.
Included is the after-hours moves and pertinent data with a snapshot as of 5:14 PM EST. Estimates are Thomson Reuters data where noted:
Conexant Systems, Inc. (NASDAQ: CNXT) closed at $2.44 and shares are trading at $2.88 up 18.03% on 67,400 shares since the closing bell. This one posted 0.11 EPS vs. $0.09 estimates; imaging and audio businesses grew 18% on a sequential basis and accounted for 58% of total revenues and is raising guidance.
Genworth Financial Inc. (NYSE: GNW) closed at $10.18 and shares are trading at $11.68 up 14.73% on 2,297,577 shares since the closing bell. This already had a monster up-day of 17% before the close, so anyone who bought yesterday cleaned house. The company posted $0.24 EPS vs a -$0.02 estimate. Revenues rose 10% to $2.39 billion, but under the $2.52B estimate. Book value per share grew 10% sequentially to $25.42 per share over the improvement in the markets.
Las Vegas Sands Corp. (NYSE: LVS) closed at $14.76 and is now trading up at $15.99 up 8.33% on 4,810,097 shares since the closing bell. That is on top of a 12% gain today and because the company beat earnings on cost cuts and announced that it has record pre-booked rooms and has more group rooms already booked for 2010 than it expects for all of 2009.
Novatel Wireless, Inc. (NASDAQ: NVTL) closed at $12.19 and shares are trading at $10.13 down by 16.90% on 661,773 shares since the closing bell. The company did beat earnings, but issues are there on guidance. Earnings were $0.20 EPS vs $0.10 EPS estimates; Revenues were up 12.1% to $94.3 million vs. $92.6 million expected. For Q4 the company sees $0.04 to $0.12 EPS and revenues of $85 to $95 million versus estimates of $0.10 EPS and $95.69 mln consensus.
Tessera Technologies, Inc. (NASDAQ: TSRA) closed at $26.86 and shares are trading at $22.55 down by 16.05% on 62,124 shares since the closing bell. Earnings were $0.24 EPS and revenues were up 4% at $66.1 million vs. $0.21 and $65.7 million estimates. But its Q4 revenue guidance is weak at a range of $60 to $62 million vs $69.9 million expected.
JON C. OGG
Human Genome Sciences, Inc. (NASDAQ: HGSI) has been soaring today. At 2:45 PM EST we saw this one already cross a full day’s trading volume at 120% normal stock trading volume and that options were picking up throughout the day. This follows the JPMorgan upgrade to Overweight from Neutral ahead of new additional clinical data next week. Our friend over at OptionsHawk.com just sent us more details on the options trading:
Human Genome (HGSI) is trading 84,000 calls and 21,000 puts on the day after an upgrade at JP Morgan before the key November 2nd Benlysta seocnd of two Phase 3 trial data for the treatment of Lupus, which would make it the leading contender in the market for a highly lucrative potential market. Smart money has been bullish the name in recent weeks with 10,000 contract November $25/$30 call spreads and various other strategies as the common consensus is a 70% chance of the drug having a positive outcome. Despite implied volatility being at 193%, many are still betting on volatility expecting a sharper than priced in reaction. Today’s action represents 4X the average call volume, although only 1/4th of the action is offer side buying, but ISE Sentiment indicates 3 calls are being opened for every 1 put. One of the larger trades today is slightly bullish but bearish on volatility as the trader used a butterfly call spread, buying 3,500 of the November $20 and $3 0 calls, and selling 7,000 of the $25 calls, expecting shares to trade around the $25 level and for Implied Volatility to be crushed. -OPTIONSHAWK.COM
-JON C. OGG
Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) is getting destroyed and is today’s largest percentage loser by far. The FDA did not approve the comjpany’s experimental sleep disorder drug called Intermezzo. The reason was over safety issues, but the FDA has requested additional data that might require more studies. At 9:00 AM EST we have shares trading down all the way at $6.16, down 46% from the $11.47 closing price. We also have seen some 181,843 shares trade hands, double the 88,000 average. The market cap was $150 million before the cut, so you can cut that almost in half today. The company had $73.6 million in cash and short-term investments on hand at the end of the June 30 quarter. -JON OGG
American Superconductor Corporation (NASDAQ: AMSC) is not that active yet in the early hours. Yet. The company posted increased revenues of 85% to $74.7 million and non-GAAP EPS to $0.19; it generated $35.8 million in cash from operations and it increased its order backlog to $587 million. The company also raised guidance. Shares closed at $28.84 yesterday, but shares are up 15% as a top pre-market winner at $33.19 on about 22,000 shares as of 8:57 AM EST. Average volume is about 1.03 million shares, but you can expect that to be hit early with this sort of jump. The 52-week trading range is $8.22 to $39.90, so it is obviously a volatile trading stock. JON OGG